DMB Acquisition Corp.
(Note: DMB Acquisition Corp. withdrew its SPAC IPO in an SEC filing dated Sept. 22, 2022. This blank check company’s IPO had been in the works since July 2021. Unlike most SPAC IPOs, this deal was planned as a stock-only offering – no warrants.)
We intend to focus on businesses that have their primary operations located in North America in the healthcare industry. (Incorporated in Delaware)
LifeSci Holdings LLC, an entity affiliated with LifeSci Capital LLC, a research-driven investment bank with deep domain expertise in the life sciences.
It is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting companies domiciled in North America or Europe that are developing assets in the biopharma, medical technology, digital health and healthcare services sectors, which aligns with our management team’s experience in healthcare investing and drug development.
|Address||250 W 55th St #3401, New York, NY 10019|
|Phone Number||(646) 889-1200|
|View Prospectus:||DMB Acquisition Corp.|
|Revenues||$0 mil (last 12 months)|
|Net Income||$0 mil (last 12 months)|
|Price range||$10.00 - $10.00|
|Est. $ Volume||$75.0 mil|
|Manager / Joint Managers||LifeSci Capital/ Ladenburg Thalmann|
|Expected To Trade:|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|